Friday, January 8, 2021
"Alternative Treatment Strategies for Prostate Cancer"
Associate Staff, Center for GU Malignancies Research
Lerner Research Institute, Cleveland Clinic
Adjunct Assistant Professor, Department of Molecular Medicine
Member, GU Malignancies Program, Case Comprehensive Cancer Center
Case Western Reserve University School of Medicine
This seminar is presented by the GU Malignancies Program, Case Comprehensive Cancer Center.
The Heemers laboratory explores novel therapeutic vulnerabilities in prostate cancer. Prostate cancer is the second leading cause of cancer deaths in American men. With few exceptions, the 33,000 prostate cancer deaths that occur annually in the United States are due to failure of androgen deprivation therapy. Androgen deprivation therapy targets the genomic action of the androgen receptor, the major driver of prostate cancer progression. The Heemers laboratory’s research program focuses on generating insights into the specific molecular mechanisms by which the androgen receptor drives prostate cancer progression. The long term goals of her group are (1) to develop novel prostate cancer-selective forms of androgen deprivation therapy, (2) to identify new therapeutic targets to overcome acquired resistance to prostate cancer treatments, and (3) to optimize and personalize evidence-based administration of available prostate cancer therapies. Her lab pursues these goals through two major lines of research that study coregulator-dependent direct mechanisms of androgen action and an SRF-dependent indirect mechanism of androgen action. Central to their research efforts are integrated approaches that combine an understanding of the basic mechanism of androgen-dependent gene transcription, systems biology approaches designed to answer specific questions, and clinical relevance of their research findings.
These weekly seminars are now being held virtually via Zoom due to institutional health restrictions. If you are unfamiliar with Zoom, click here to view instructions and support topics. Contact Kelsey Kirsch at for more information.

To watch the seminar in real time and engage with the speaker, click the button below at 12 pm ET each Friday. Presentations are recorded but will not be available for later viewing.
To ensure a great virtual seminar experience for all, we have collected a few virtual seminar tips for attendees:

  • All participants are muted upon entry. Please remain muted during the presentation with your video off to decrease distractions.
  • If you experience poor audio quality, click the arrow to the right of the microphone icon in the toolbar. Select 'Switch to Phone Audio' and dial-in manually using the toll number, as most cell-phone plans and many landline contracts offer unlimited talk minutes.
  • Questions are welcomed and encouraged!
  • Using the chat function in the Zoom toolbar, type in your question at any point and it will be read by the moderator at an appropriate time.
  • When the presenter asks for questions, you may choose to unmute yourself by clicking the microphone or phone icon to ask your question directly. Please wait for an appropriate time to do so.
  • Please help us make speakers feel welcomed and appreciated. When the seminar speaker has completed their presentation, please unmute your audio and clap for them, just as we would in-person.
  • Different view and layout options are available in Zoom.
  • When in the seminar and viewing a presenter's screen, click 'View Options' and choose 'Side-by-Side Mode' to see both the presenter and the shared content. The middle separator can be slid either way to adjust the size of the view.
  • Speaker view is also available in the upper right corner, allowing you to view just the speaker and their shared content in a different layout.

CME credit is still available for those who attend seminars live via Zoom. This Friday's CME claim code is: 44739.
Seminars are currently being held virtually via Zoom.
Betsy DeWindt Chair, Department of Cancer Biology
Director, Global and Emerging Pathogen Research Center
Lerner Research Institute, Cleveland Clinic
Member, Molecular Oncology Program, Case Comprehensive Cancer Center
Case Western Reserve University School of Medicine

"TRIM56: Intracellular DNA Sensing Pathway and Nonalcoholic Fatty Liver Disease"

Presented by the Molecular Oncology Program
Deputy Director, MetroHealth Cancer Center
Director, Division of Hematology/Oncology, MetroHealth Medical Center
Member, Hematopoietic and Immune Cancer Biology Program
Case Comprehensive Cancer Center
Case Western Reserve University School of Medicine

Presented by the Hematopoietic and Immune Cancer Biology Program
PHASE ONE Foundation Distinguished Chair
Director, Cedars-Sinai Cancer
Professor, Surgery
Professor, Pathology and Laboratory Medicine
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai

Presented by the GU Malignancies Program
March 4-5, 2021
Registration and abstract submission now open.
May 23-25, 2021
2020 Conference rescheduled - sign up to receive updates!
Case Comprehensive Cancer Center | Website